Noveris Health Sciences Provides Corporate Update, and Announces Agreement for Acquisition of Stem Cell Distribution Business

Vancouver, British Columbia – TheNewswire - April 29, 2026 – Noveris Health Sciences Inc. (the “ Company ”, or “ Noveris ”) (CSE: NVRS) (FSE: 0NF0) (OTC: MYCOF) wishes to provide a corporate update. Noveris is a biotech and life sciences company dedicated to developing and commercializing innovative solutions for treating mental health problems and enhancing vitality.  Following completion of the Company's debt restructuring, and its recent successful financing for gross proceeds of CDN $2.3 million, the Company now intends to focus on two primary business objectives: (1) commercializing its patent portfolio, and (2) developing and commercializing therapies and technologies based on stem cell biology.